Menu
Asthma
Seretide is indicated in the regular treatment of asthma where use of a combination
product (long-acting-beta2-agonist and inhaled corticosteroid) is appropriate:
– Patients not adequately controlled with inhaled corticosteroids and “as needed”
inhaled short-acting-beta2-agonist
Batch: MS4C | Exp: 07/09/2024
Regular treatment of COPD including chronic bronchitis & emphysema. Accuhaler: Regular treatment of asthma in childn & adults. Evohaler: Regular treatment of reversible obstructive airway disease (ROAD) including asthma in childn & adults.
| Weight | 0.2 kg |
|---|
